Clinical and Economic Impact of an Electronic Medical Record Interfaced Decision Support System for Minimizing Severe Drug-Drug Interactions (DDI+)

This study is not yet open for participant recruitment.

Verified January 2013 by Leumit Health Services

Sponsor:

Information provided by (Responsible Party):

Leumit Health Services

ClinicalTrials.gov Identifier:

NCT01765595

First received: January 9, 2013

Last updated: NA

Last verified: January 2013

History: No changes posted

Purpose

Leumit Health Services, an health maintenance organization operating in Israel, will incorporate a web-based, decision support system for handling drug-drug interactions and drug information, termed DDI+. the investigators hypothesize that implementing such a system will reduce health-care expenditures (e.g., hospital admissions, referrals to ERs, Imaging procedures).

Condition	Intervention
Healthcare	Other: DDI+

Study Type:	Interventional
Study Design:	Allocation: Non-Randomized Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Health Services Research

Resource links provided by NLM:

MedlinePlus related topics: Drug Reactions

U.S. FDA Resources

Further study details as provided by Leumit Health Services:

Primary Outcome Measures:

Hospital Admissions [ Time Frame: up to 12 months post initiation ] [ Designated as safety issue: Yes ]

Estimated Enrollment:	150000
Study Start Date:	January 2013
Estimated Study Completion Date:	June 2014
Estimated Primary Completion Date:	January 2014 (Final data collection date for primary outcome measure)

Arms	Assigned Interventions
Experimental: DDI+ DDI+ Incorporated in routine ambulatory practice	Other: DDI+
No Intervention: Control Standard care

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	Yes

Criteria

Inclusion Criteria:

Number of chronic concomitant drugs ≥5

Exclusion Criteria:

Patients diagnosed with HIV/AIDS, and/or viral hepatitis B or C.

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT01765595

Contacts

Contact: Abraham Weizman, MD

+972-50-7277123

AWeizman@clalit.org.il

Locations

Israel
Leumit Health Services	Not yet recruiting
Tel-Aviv, Israel
Contact: Natan R Kahan, PhD
Principal Investigator: Abraham Weizman, MD
Principal Investigator: Mati Berkowitz, MD

Sponsors and Collaborators

Leumit Health Services

Investigators

Principal Investigator:

Abraham Weizman, MD

Tel Aviv University

More Information

No publications provided

Responsible Party:	Leumit Health Services
ClinicalTrials.gov Identifier:	NCT01765595 History of Changes
Other Study ID Numbers:	LHS012013
Study First Received:	January 9, 2013
Last Updated:	January 9, 2013
Health Authority:	Israel: Ministry of Health

Keywords provided by Leumit Health Services:

health care expenditure
drug drug interactions
electronic decision support systems
Potential reduction

ClinicalTrials.gov processed this record on May 19, 2013

To Top